OncoMatch/Clinical Trials/NCT01185132
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Is NCT01185132 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for breast cancer.
In the setting of radiotherapy as part of breast-conservation therapy for patients with early stage breast cancer, the novel planning and delivery method of intensity modulated radiotherapy is an effective and safe alternative to the commonly-used standard 3D-conformal external beam radiotherapy, spares more normal breast and lung tissue, and may lead to improved clinical outcomes.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Disease stage
Required: Stage TIS (AJC)
Grade: high nuclear grade DCIS
Histologically confirmed disease (AJC Classification): Tis, T1, T2 (≤ 3.0 cm), N0, M0.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Rocky Mountain Cancer Centers - Aurora · Aurora, Colorado
- Rocky Mountain Cancer Centers - Boulder · Boulder, Colorado
- Rocky Mountain Cancer Centers - Lakewood · Lakewood, Colorado
- Rocky Mountain Cancer Centers - Littleton · Littleton, Colorado
- Rocky Mountain Cancer Centers - Thornton · Thornton, Colorado
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify